References
- Almagro Armenteros, J. J., Tsirigos, K. D., Sønderby, C. K., Petersen, T. N., Winther, O., Brunak, S., von Heijne, G., & Nielsen, H. (2019). SignalP 5.0 improves signal peptide predictions using deep neural networks. Nature Biotechnology, 37(4), 420–423. https://doi.org/https://doi.org/10.1038/s41587-019-0036-z
- Al-Qahtani, A. A., Al-Anazi, M. R., Nazir, N., Abdo, A. A., Sanai, F. M., Al-Hamoudi, W. K., Alswat, K. A., Al-Ashgar, H. I., Khan, M. Q., Albenmousa, A., El-Shamy, A., Alanazi, S. K., Dela Cruz, D., Bohol, M. F. F., & Al-Ahdal, M. N. (2018). The correlation between hepatitis B virus precore/core mutations and the progression of severe liver disease. Frontiers in Cellular and Infection Microbiology, 8, 355. https://doi.org/https://doi.org/10.3389/fcimb.2018.00355
- Beard, H., Cholleti, A., Pearlman, D., Sherman, W., & Loving, K. A. (2013). Applying physics-based scoring to calculate free energies of binding for single amino acid mutations in protein-protein complexes. PLoS One, 8(12), e82849. https://doi.org/https://doi.org/10.1371/journal.pone.0082849
- Bertoletti, A., Costanzo, A., Chisari, F. V., Levrero, M., Artini, M., Sette, A., Penna, A., Giuberti, T., Fiaccadori, F., & Ferrari, C. (1994). Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. The Journal of Experimental Medicine, 180(3), 933–943. https://doi.org/https://doi.org/10.1084/jem.180.3.933
- Bertoletti, A., & Ferrari, C. (2016). Adaptive immunity in HBV infection. Journal of Hepatology, 64(1 Suppl), S71–S83. https://doi.org/https://doi.org/10.1016/j.jhep.2016.01.026
- Bertoletti, A., & Le Bert, N. (2018). Immunotherapy for chronic hepatitis B virus infection. Gut and Liver, 12(5), 497–507. https://doi.org/https://doi.org/10.5009/gnl17233
- Buchan, D. W. A., & Jones, D. T. (2019). The PSIPRED protein analysis workbench: 20 years on. Nucleic Acids Research, 47(W1), W402–W407. https://doi.org/https://doi.org/10.1093/nar/gkz297
- Cossart, Y., & Field, A. (1970). Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. The Lancet, 295(7651), 848.
- Francisco, J. C., Dai, Q., Luo, Z., Wang, Y., Chong, R. H.-H., Tan, Y. J., Xie, W., Lee, G.-H., & Lin, C. (2017). Transcriptional elongation control of hepatitis B virus covalently closed circular DNA transcription by super elongation complex and BRD4. Molecular and Cellular Biology, 37(19). https://doi.org/https://doi.org/10.1128/MCB.00040-17
- Fu-Sheng, W., Jian-Gao, F., Zheng, Z., Bin, G., & Hong-Yang, W. (2014). The global burden of liver disease: The major impact of China. Hepatology, 60(6), 2099–2108. https://doi.org/https://doi.org/10.1002/hep.27406
- Fusheng, Z. (2016). Deep sequencing of the MHC region in the Chinese population contributes to studies of complex disease. Nature Genetics, 7(48), 740–746.
- González-Galarza, F. F., Takeshita, L. Y., Santos, E. J., Kempson, F., Maia, M. H. T., Silva, A. L. S. D., Silva, A. L. T. E., Ghattaoraya, G. S., Alfirevic, A., Jones, A. R., & Middleton, D. (2015). Allele frequency net 2015 update: New features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. Nucleic Acids Research, 43, 784–788.
- Gragert, L., Madbouly, A., Freeman, J., & Maiers, M. (2013). Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry. Human Immunology, 74(10), 1313–1320. https://doi.org/https://doi.org/10.1016/j.humimm.2013.06.025
- Gripon, P., Cannie, I., & Urban, S. (2005). Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. Journal of Virology, 79(3), 1613–1622. https://doi.org/https://doi.org/10.1128/JVI.79.3.1613-1622.2005
- Hayer, J., Jadeau, F., Deleage, G., Kay, A., Zoulim, F., & Combet, C. (2013). HBVdb: A knowledge database for Hepatitis B virus. Nucleic Acids Research, 41(D1), D566–570. https://doi.org/https://doi.org/10.1093/nar/gks1022
- Jurtz, V., Paul, S., Andreatta, M., Marcatili, P., Peters, B., & Nielsen, M. (2017). NetMHCpan-4.0: Improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data. Journal of Immunology (Baltimore, Md. : 1950)), 199(9), 3360–3368. https://doi.org/https://doi.org/10.4049/jimmunol.1700893
- Ke, S. (2015). Understanding amino acid mutations in hepatitis B virus proteins for rational design of vaccines and drugs. Advances in Protein Chemistry and Structural Biology, 99, 131–153.
- Krogh, A., Larsson, B., von Heijne, G., & Sonnhammer, E. L. (2001). Predicting transmembrane protein topology with a hidden Markov model: Application to complete genomes. Journal of Molecular Biology, 305(3), 567–580. https://doi.org/https://doi.org/10.1006/jmbi.2000.4315
- Kumar, S., Stecher, G., & Tamura, K. (2016). MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Molecular Biology and Evolution, 33(7), 1870–1874. https://doi.org/https://doi.org/10.1093/molbev/msw054
- Levrero, M., & Zucman-Rossi, J. (2016). Mechanisms of HBV-induced hepatocellular carcinoma. Journal of Hepatology, 64(1 Suppl), S84–S101. https://doi.org/https://doi.org/10.1016/j.jhep.2016.02.021
- Lianhong, X. (2010). Up-regulate HLA class I expression following hepatitis B virus transfection in a hepatocellular carcinoma cell line BEL7405. Immunological Investigations, 6(39), 621–634.
- Li, X., Liu, Y., Xu, Z., Wan, Z., Bai, S., Mao, P., Mao, Y., Xin, S., & Xu, D. (2013). A complete genomic analysis of hepatitis B virus isolated from 516 Chinese patients with different clinical manifestations. Journal of Medical Virology, 85(10), 1698–1704. https://doi.org/https://doi.org/10.1002/jmv.23640
- Li, S., Qian, J., Yang, Y., Zhao, W., Dai, J., Bei, J.-X., Foo, J. N., McLaren, P. J., Li, Z., Yang, J., Shen, F., Liu, L., Yang, J., Li, S., Pan, S., Wang, Y., Li, W., Zhai, X., Zhou, B., … Zhou, W. (2012). GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genetics, 8(7), e1002791. https://doi.org/https://doi.org/10.1371/journal.pgen.1002791
- Loras, C., Gisbert, J. P., Mínguez, M., Merino, O., Bujanda, L., Saro, C., Domenech, E., Barrio, J., Andreu, M., Ordás, I., & Vida, L. (2010). Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy. Gut, 59(10), 1340–1346.
- Lumley, S., Noble, H., Hadley, M. J., Callow, L., Malik, A., Chua, Y. Y., Duffey, O. J., Grolmusova, N., Kumar, A., Ravenscroft, S., Spencer, J. I., Neumann-Haefelin, C., Thimme, R., Andersson, M., Klenerman, P., Barnes, E., & Matthews, P. C. (2016). Hepitopes: A live interactive database of HLA class I epitopes in hepatitis B virus. Wellcome Open Research, 1, 9. https://doi.org/https://doi.org/10.12688/wellcomeopenres.9952.1
- Luna, C. (2018). Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe. BMC Infectious Diseases, 1(18).
- Pan, N., Chen, K., Qiu, J., Sun, H., Xu, J., Miao, F., Shi, Q., Jiang, W., Jin, H., He, Y., Xie, W., & Zhang, J. (2013). Human leukocyte antigen class I alleles and haplotypes associated with primary hepatocellular carcinoma in persistent HBV-infected patients. Human Immunology, 74(6), 758–763. https://doi.org/https://doi.org/10.1016/j.humimm.2013.02.007
- Phillip, P. (2017). MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape. Nature Structural & Molecular Biology, 4(24), 387–394.
- Piao, L., Chen, Z., Li, Q., Liu, R., Song, W., & Kong, R. (2019). Molecular dynamics simulations of wild type and mutants of SAPAP in complexed with Shank3. International Journal of Molecular Sciences., 20(1). https://doi.org/https://doi.org/10.3390/ijms20010224
- Riedl, P., Bertoletti, A., Lopes, R., Lemonnier, F., Reimann, J., & Schirmbeck, R. (2006). Distinct, cross-reactive epitope specificities of CD8 T cell responses are induced by natural hepatitis B surface antigen variants of different hepatitis B virus genotypes. The Journal of Immunology, 176(7), 4003–4011.
- Rivino, L., Tan, A. T., Chia, A., Kumaran, E. A., Grotenbreg, G. M., MacAry, P. A., & Bertoletti, A. (2013). Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity. Journal of Immunology (Baltimore, Md.: 1950), 191(8), 4010–4019.
- Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221–234. https://doi.org/https://doi.org/10.1007/s10822-013-9644-8
- Schuch, A., Hoh, A., & Thimme, R. (2014). The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection. Frontiers in Immunology, 5, 258. https://doi.org/https://doi.org/10.3389/fimmu.2014.00258
- Shen, B., & Vihinen, M. (2004). Conservation and covariance in PH domain sequences: Physicochemical profile and information theoretical analysis of XLA-causing mutations in the Btk PH domain. Protein Engineering Design and Selection, 17(3), 267–276. https://doi.org/https://doi.org/10.1093/protein/gzh030
- Shen, Y., Xia, M., Zhang, J., Xu, L., Yang, J., Chen, A., Miao, F., Ferrone, S., & Xie, W. (2009). IRF-1 and p65 mediate upregulation of constitutive HLA-A antigen expression by hepatocellular carcinoma cells. Molecular Immunology, 46(10), 2045–2053.
- Sunbul, M. (2014). Hepatitis B virus genotypes: Global distribution and clinical importance. World Journal of Gastroenterology, 20(18), 5427–5434.
- Tan, A. T., Loggi, E., Boni, C., Chia, A., Gehring, A. J., Sastry, K. S. R., Goh, V., Fisicaro, P., Andreone, P., Brander, C., Lim, S. G., Ferrari, C., Bihl, F., & Bertoletti, A. (2008). Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire. Journal of Virology, 82(22), 10986–10997. https://doi.org/https://doi.org/10.1128/JVI.01124-08
- Tong, S., & Revill, P. (2016). Overview of hepatitis B viral replication and genetic variability. Journal of Hepatology: The Journal of the European Association for the Study of the Liver, 64(1S), S4–S16.
- Trolle, T., McMurtrey, C. P., Sidney, J., Bardet, W., Osborn, S. C., Kaever, T., Sette, A., Hildebrand, W. H., Nielsen, M., & Peters, B. (2016). The length distribution of class I-restricted T cell epitopes is determined by both peptide supply and MHC allele-specific binding preference. Journal of Immunology (Baltimore, Md. : 1950)), 196(4), 1480–1487. https://doi.org/https://doi.org/10.4049/jimmunol.1501721
- Wang, J., Lee, A. S., & Ou, J. H. (1991). Proteolytic conversion of hepatitis B virus e antigen precursor to end product occurs in a postendoplasmic reticulum compartment. Journal of Virology, 65(9), 5080–5083. https://doi.org/https://doi.org/10.1128/JVI.65.9.5080-5083.1991
- Webster, G. J. M., Reignat, S., Brown, D., Ogg, G. S., Jones, L., Seneviratne, S. L., Williams, R., Dusheiko, G., & Bertoletti, A. (2004). Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: Implications for immunotherapy. Journal of Virology, 78(11), 5707–5719. https://doi.org/https://doi.org/10.1128/JVI.78.11.5707-5719.2004
- Wei, F., Zheng, Q., Li, M., & Wu, M. (2017). The association between hepatitis B mutants and hepatocellular carcinoma: A meta-analysis. Medicine, 96(19), e6835 https://doi.org/https://doi.org/10.1097/MD.0000000000006835
- Ylilauri, M., & Pentikainen, O. T. (2013). MMGBSA as a tool to understand the binding affinities of filamin-peptide interactions. Journal of Chemical Information and Modeling, 53(10), 2626–2633. https://doi.org/https://doi.org/10.1021/ci4002475